These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5819636)

  • 1. The crystal and molecular structure of quinuclidinyl benzilate hydrobromide.
    Meyerhöffer A; Carlström D
    Acta Crystallogr B Struct Crystallogr Cryst Chem; 1969 Jun; 25(6):1119-26. PubMed ID: 5819636
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogues of 3-quinuclidinyl benzilate.
    Rzeszotarski WJ; Gibson RE; Eckelman WC; Simms DA; Jagoda EM; Ferreira NL; Reba RC
    J Med Chem; 1982 Sep; 25(9):1103-6. PubMed ID: 7131491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Quinuclidinyl benzilate hydrolysis in dilute aqueous solution.
    Hull LA; Rosenblatt DH; Epstein J
    J Pharm Sci; 1979 Jul; 68(7):856-9. PubMed ID: 37323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of the muscarinic receptor antagonist, [3-3H]quinuclidinyl benzilate, to Torpedo marmorata membrane fragments [proceedings].
    Pickard MR; Strange PG
    Biochem Soc Trans; 1978; 6(1):129-31. PubMed ID: 640140
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific [3H]quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain.
    Hurko O
    Arch Biochem Biophys; 1978 Oct; 190(2):434-45. PubMed ID: 718161
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative inhibitory effects of 3-quinuclidinyl benzilate (QNB) and atropine on amylase release from rat pancreas.
    Morisett J; Ng KH; Poirier GG
    Br J Pharmacol; 1977 Sep; 61(1):97-100. PubMed ID: 912213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and conformation activity relationships of heterocyclic acetylcholine analogues. X. The inhibitory effect of 3-quinuclidinyl benzilates on cardiac muscarinic receptors.
    Lambrecht G
    Arzneimittelforschung; 1980; 30(12):2113-5. PubMed ID: 7194070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiacetylcholine activities of psychoactive drugs: a comparison of the [3H]quinuclidinyl benzilate binding assay with conventional methods.
    Sayers AC; Bürki HR
    J Pharm Pharmacol; 1976 Mar; 28(3):252-3. PubMed ID: 6704
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic receptors of the pancreas: a correlation between displacement of (3 H)-quinuclidinyl benzilate binding and amylase secretion.
    Ng KH; Morisset J; Poirier GG
    Pharmacology; 1979; 18(5):263-70. PubMed ID: 482346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute configuration of 3-quinuclidinyl benzilate and the behavioral effect in the dog of the optical isomers.
    Meyerhöffer A
    J Med Chem; 1972 Sep; 15(9):994-5. PubMed ID: 5051020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of glycolate esters on conditioned behavior].
    Mei ZT
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):1-3. PubMed ID: 3158150
    [No Abstract]   [Full Text] [Related]  

  • 12. Affinity labeling of muscarinic receptors in rat cerebral cortex with a photolabile antagonist.
    Amitai G; Avissar S; Balderman D; Sokolovsky M
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):243-7. PubMed ID: 6952181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-binding relationship of quinuclidinyl benzilate analogs on N4TG1 neuroblastoma muscarinic receptors.
    Chang YF
    Neurochem Res; 1988 May; 13(5):455-62. PubMed ID: 3405371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists.
    Rzeszotarski WJ; McPherson DW; Ferkany JW; Kinnier WJ; Noronha-Blob L; Kirkien-Rzeszotarski A
    J Med Chem; 1988 Jul; 31(7):1463-6. PubMed ID: 3385735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE; Eckelman WC; Vieras F; Reba RC
    J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilate.
    Gibson RE; Schneidau TA; Cohen VI; Sood V; Ruch J; Melograna J; Eckelman WC; Reba RC
    J Nucl Med; 1989 Jun; 30(6):1079-87. PubMed ID: 2738688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells.
    Strange PG; Birdsall NJ; Burgen AS
    Biochem J; 1978 Jun; 172(3):495-501. PubMed ID: 567477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Zeeberg BR; Eckelman WC
    Nucl Med Biol; 1996 Oct; 23(7):889-96. PubMed ID: 8971856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.